Intralesional injections of rhIL-12 result in tumor regression. (A) Tumor of the right forearm at baseline in patient 5. (B) Complete flattening of the tumor at week 3 after 6 injections of rhIL-12 at a dose of 100 ng/kg into the tumor. Histologic examination of the flattened tumor showed complete resolution of the malignant infiltrate.